Cargando…

In Vitro Effects of Mitochondria-Targeted Antioxidants in a Small-Cell Carcinoma of the Ovary of Hypercalcemic Type and in Type 1 and Type 2 Endometrial Cancer

Small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT) and endometrial cancer from type 1 and type 2 are gynecological tumors that affect women worldwide. The treatment encompasses the use of cytotoxic drugs that are nonspecific and inefficient. “Mitocans”, a family of drugs that specifica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castelôa, Mariana, Moreira-Pinto, Beatriz, Benfeito, Sofia, Borges, Fernanda, Fonseca, Bruno M., Rebelo, Irene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030827/ https://www.ncbi.nlm.nih.gov/pubmed/35453550 http://dx.doi.org/10.3390/biomedicines10040800

Ejemplares similares

Small Cell Carcinoma of the Ovary of Hypercalcemic Type: A Case Report
por: Zaied, S., et al.
Publicado: (2012)

Prophylactic oophorectomy for hereditary small cell carcinoma of the ovary, hypercalcemic type
por: Berchuck, Andrew, et al.
Publicado: (2015)

Small Cell Carcinoma of the Ovary (Hypercalcemic Type): Malignant Rhabdoid Tumor
por: Kascak, Peter, et al.
Publicado: (2016)

Molecular Characterization of a Patient's Small Cell Carcinoma of the Ovary of the Hypercalcemic Type
por: Stephens, Bret, et al.
Publicado: (2012)

Multimodal molecular analysis of an atypical small cell carcinoma of the ovary, hypercalcemic type
por: David, Marjorie P., et al.
Publicado: (2018)

The dilemma of early preventive oophorectomy in familial small cell carcinoma of the ovary of hypercalcemic type
por: Pejovic, Tanja, et al.
Publicado: (2019)

Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)
por: Ramos, Pilar, et al.
Publicado: (2014)

The hereditary nature of small cell carcinoma of the ovary, hypercalcemic type: two new familial cases
por: Witkowski, Leora, et al.
Publicado: (2016)

Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type
por: Jelinic, Petar, et al.
Publicado: (2016)

Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade
por: Jelinic, Petar, et al.
Publicado: (2018)

Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): A rare case after in vitro fertilization (IVF)
por: Ghazi, Ahmed, et al.
Publicado: (2017)

Risk reduction for small cell cancer of the ovary, hypercalcemic type in prepubertal patient: A clinical and bioethical perspective
por: Vu, John A., et al.
Publicado: (2023)

Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT): Patient Characteristics, Treatment, and Outcome—A Systematic Review
por: Wens, Francis S. P. L., et al.
Publicado: (2023)

An In-Depth Look at Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT): Clinical Implications from Recent Molecular Findings
por: Lu, Bingjian, et al.
Publicado: (2019)

Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis
por: Auguste, Aurélie, et al.
Publicado: (2020)

Small Cell Carcinoma of Ovary, Hypercalcemic Type (Malignant Rhabdoid Tumor of Ovary) with Loss of SMARCA4 (BRG1) Expression: Report of Two Cases
por: Sahay, Ayushi, et al.
Publicado: (2020)

Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumor
por: Fahiminiya, Somayyeh, et al.
Publicado: (2015)

Successful pregnancy following chemotherapy in a survivor of small cell carcinoma of the ovary, hypercalcemic type (SCCOHT): A case report and review of literature()
por: Phoolcharoen, Natacha, et al.
Publicado: (2020)

Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): A review and novel case with dual germline SMARCA4 and BRCA2 mutations
por: Sanders, Brooke E., et al.
Publicado: (2022)

Case Report: A Durable Response to Camrelizumab and Apatinib Combination Therapy in a Heavily Treated Small Cell Carcinoma of the Ovary, Hypercalcemic Type
por: Li, Guiling, et al.
Publicado: (2022)

Case Report of Small Cell Carcinoma of the Ovary, Hypercalcemic Type (Ovarian Rhabdoid Tumor) with SMARCB1 Mutation: A Literature Review of a Rare and Aggressive Condition
por: Simões, Maria Fernanda Evangelista, et al.
Publicado: (2022)

Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type
por: Moes-Sosnowska, Joanna, et al.
Publicado: (2015)

Advanced small-cell ovarian carcinoma, hypercalcemic type: a challenging therapeutic entity
por: Bitton, Rafael Caparica, et al.
Publicado: (2014)

SAT-231 A Case of Small Cell Ovarian Cancer, Hypercalcemic Type, in Pregnancy
por: Polu, Shruti, et al.
Publicado: (2019)

Hypercalcemic Disorders in Children
por: Stokes, Victoria J, et al.
Publicado: (2017)

Adult T-type lymphoblastic lymphoma presenting as hypercalcemic crisis and aplastic anemia: a case report
por: Essouma, Mickael, et al.
Publicado: (2019)

Exploring the Multi-Target Performance of Mitochondriotropic Antioxidants against the Pivotal Alzheimer’s Disease Pathophysiological Hallmarks
por: Benfeito, Sofia, et al.
Publicado: (2020)

Cytotoxicity and Mitochondrial Effects of Phenolic and Quinone-Based Mitochondria-Targeted and Untargeted Antioxidants on Human Neuronal and Hepatic Cell Lines: A Comparative Analysis
por: Fernandes, Carlos, et al.
Publicado: (2021)

Ovarian small-cell carcinoma hypercalcemic type successfully treated: a case report and literature review
por: Wang, Jian-jun, et al.
Publicado: (2016)

Primary ovarian small cell carcinoma of hypercalcemic type in a pregnant woman: A case report
por: Feng, Min, et al.
Publicado: (2020)

A Case of Endometrial Stromal Sarcoma with Synchronous Bilateral Adenocarcinoma of Ovary
por: Caramelo, Olga, et al.
Publicado: (2012)

Re-expression of SMARCA4/BRG1 in small cell carcinoma of ovary, hypercalcemic type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism
por: Orlando, Krystal Ann, et al.
Publicado: (2020)

Hypercalcemic crisis induced by calcium carbonate
por: Singh, Ashutosh, et al.
Publicado: (2012)

Hypercalcemic Encephalopathy as the Presenting Manifestation of Sarcoidosis
por: Kumar Prusty, B. Saroj, et al.
Publicado: (2019)

A rare case report of multiple myeloma presenting with paralytic ileus and type II respiratory failure due to hypercalcemic crisis
por: Guo, Yuchen, et al.
Publicado: (2017)

Low Doses of Resveratrol Protect Human Granulosa Cells from Induced-Oxidative Stress
por: Moreira-Pinto, Beatriz, et al.
Publicado: (2021)

Lethal Visceral Calcinosis in Fulminant Hypercalcemic Crisis
por: Yoshihara, Shu, et al.
Publicado: (2017)

Hypercalcemic Encephalopathy as an Initial Presentation of Multiple Myeloma
por: Meena, Durga Shankar, et al.
Publicado: (2020)

Calcium Carbonate (Tums)-Associated Hypercalcemic Crisis
por: Jain, Hanish, et al.
Publicado: (2022)

Planned parathyroidectomy: the new standard in hypercalcemic crisis
por: Neves, Murilo Catafesta das, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hqvo45urnvlek3l9s89827kh5t